COVID-19 and the RISE of DIGITAL PATHOLOGY
You asked the questions - the Experts answered you!
Watch this fascinating webcast on digital pathology in the time of COVID-19 and glean knowledge from questions asked by your colleagues and answered by pathologists.
COVID-19 AND THE RISE OF DIGITAL PATHOLOGY - WEBCAST
When the FDA exercised regulatory discretion regarding how digital pathology systems could be utilized, many pathologists took advantage of the sign-out flexibility to minimize COVID-19 exposure risks and provide timely diagnoses.
As digital pathology rose to the occasion and delivered on its promise of diagnosis from a remote location, it is important that digital pathology systems be properly implemented and validated.
Leica Biosystems is proud to provide the information you need to be informed and prepared.
Customer Questions – Experts Answer
Dr. Eric Glassy, a renowned speaker on Digital Pathology and Dr. Matthew Hanna, Director of Digital Pathology Informatics at Memorial Sloan Kettering Cancer Center have responded to the most frequently asked questions during the Covid-19 and the Rise of Digital Pathology webcast.
Review the questions asked by your peers – answered by the experts.
We’ve compiled them all into an easy to navigate format that you can access right now.
Reap the benefits of the knowledge imparted by these two, industry experts.